| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |